Y.S.P. Southeast Asia Holding Berhad, an investment holding company, operates as a pharmaceutical company. Its prescription and non-prescription products in various therapeutic areas, including antibiotics, antifungals, antacids, anti-diabetics, anti-platelets, antivirals, injectables, and eye drops in gel, capsule, tablet, suppository, cream, syrup, suspension, and powder dosage forms. It also provides veterinary pharmaceutical products for aquatic and livestock, such as anthelmintics, antibiotics, antiprotos, antifungals, disinfectants, drying agents, electrolytes, enzymes preparations, herbal extracts, hormones preparations, probiotics, vitamins and minerals supplements, antimicrobial, immune-enhancers, and larval feeds. In addition, the company offers disposables, medical devices and aids, test kits, insect repellents, biotechnology products, cosmetics, and food supplements; and management services, as well as imports, exports, and trades in pharmaceutical, traditional herbal, and veterinary products. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, Indonesia, and internationally. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.
Subscribe to have timely investment tips, articles and ideas delivered weekly to your inbox.
Investing Malaysia provides Bursa Malaysia’s share price information, Quarter Report History, Forecast, Fundamental Analysis for all the listed companies in Bursa Malaysia. All listed companies will be ranked based on our analysis.
This website is not an investment advisory service. All the information contained in this website should be treated for information purposes only. Viewers are advised to fully investigate/study before making any investment.